Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1

por Takahashi, Ryou-u, Miyazaki, Hiroaki, Takeshita, Fumitaka, Yamamoto, Yusuke, Minoura, Kaho, Ono, Makiko, Kodaira, Makoto, Tamura, Kenji, Mori, Masaki, Ochiya, Takahiro
Publicado 2015

Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Tamura, Kenji, Tanabe, Yuko, Yonemori, Kan, Yoshino, Takayuki, Fuse, Nozomu, Kodaira, Makoto, Bando, Hideaki, Noguchi, Kazuo, Shimamoto, Takashi, Ohtsu, Atsushi
Publicado 2015

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site

por Sato, Jun, Shimoi, Tatsunori, Shimomura, Akihiko, Noguchi, Emi, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Yoshida, Masayuki, Tamura, Kenji
Publicado 2019

Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours

por Yonemori, Kan, Tamura, Kenji, Kodaira, Makoto, Fujikawa, Koshi, Sagawa, Tamotsu, Esaki, Taito, Shirakawa, Tsuyoshi, Hirai, Fumihiko, Yokoi, Yuki, Kawata, Toshio, Hatano, Ben, Takahashi, Yasuo
Publicado 2016

Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma

por Kobayashi, Kenya, Matsumoto, Fumihiko, Kodaira, Makoto, Mori, Taisuke, Murakami, Naoya, Yoshida, Akihiko, Maki, Daisuke, Teshima, Masanori, Fukasawa, Masahiko, Itami, Jun, Asai, Masahiro, Yoshimoto, Seiichi
Publicado 2016

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

por Iizumi, Sakura, Shimoi, Tatsunori, Tsushita, Natsuko, Bun, Seiko, Shimomura, Akihiko, Noguchi, Emi, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado 2017

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site

por Kodaira, Makoto, Yonemori, Kan, Shimoi, Tatsunori, Yoshida, Akihiko, Yoshida, Masayuki, Kitano, Atsuko, Shimomura, Akihiko, Yunokawa, Mayu, Shimizu, Chikako, Takiguchi, Yuichi, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado 2018

Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft‐tissue sarcoma

por Yonemori, Kan, Kodaira, Makoto, Satoh, Taroh, Kudo, Toshihiro, Takahashi, Shunji, Nakano, Kenji, Ando, Yuichi, Shimokata, Tomoya, Mori, Joji, Inoue, Koichi, Oakley, Gerard J., Sakaguchi, Sachi, Tamura, Kenji
Publicado 2018

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

por Sasaki, Yasutsuna, Miwa, Keisuke, Yamashita, Keishi, Sunakawa, Yu, Shimada, Ken, Ishida, Hiroo, Hasegawa, Kosei, Fujiwara, Keiichi, Kodaira, Makoto, Fujiwara, Yasuhiro, Namiki, Masayuki, Matsuda, Minami, Takeuchi, Yutaka, Katsumata, Noriyuki
Publicado 2014

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

por Tamura, Kenji, Hashimoto, Jun, Tanabe, Yuko, Kodaira, Makoto, Yonemori, Kan, Seto, Takashi, Hirai, Fumihiko, Arita, Shuji, Toyokawa, Gouji, Chen, Lan, Yamamoto, Hiroshi, Kawata, Toshio, Lindemann, Justin, Esaki, Taito
Publicado 2016

Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients

por Tamura, Kenji, Mukai, Hirofumi, Naito, Yoichi, Yonemori, Kan, Kodaira, Makoto, Tanabe, Yuko, Yamamoto, Noboru, Osera, Shozo, Sasaki, Masaoki, Mori, Yuko, Hashigaki, Satoshi, Nagasawa, Takashi, Umeyama, Yoshiko, Yoshino, Takayuki
Publicado 2016

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer

por Kitano, Atsuko, Ono, Makiko, Yoshida, Masayuki, Noguchi, Emi, Shimomura, Akihiko, Shimoi, Tatsunori, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tsuda, Hitoshi, Tamura, Kenji
Publicado 2017

Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor‐positive advanced breast cancer

por Tamura, Kenji, Kodaira, Makoto, Shimizu, Chikako, Yonemori, Kan, Yunokawa, Mayu, Shimomura, Akihiko, Kobayashi, Takayuki, Nakano, Kenji, Tomomatsu, Junichi, Ito, Yoshinori, Tanaka, Jun, Kuriki, Hiroshi, Gu, Zhaodi, Takahashi, Shunji
Publicado 2018

Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study

por Niikura, Ryota, Hirata, Yoshihiro, Suzuki, Nobumi, Yamada, Atsuo, Hayakawa, Yoku, Suzuki, Hirobumi, Yamamoto, Shinzo, Nakata, Ryo, Komatsu, Junko, Okamoto, Makoto, Kodaira, Makoto, Shinozaki, Tomohiro, Fujishiro, Mitsuhiro, Watanabe, Toshiaki, Koike, Kazuhiko
Publicado 2017

(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients

por Kurihara, Hiroaki, Hamada, Akinobu, Yoshida, Masayuki, Shimma, Schuichi, Hashimoto, Jun, Yonemori, Kan, Tani, Hitomi, Miyakita, Yasuji, Kanayama, Yousuke, Wada, Yasuhiro, Kodaira, Makoto, Yunokawa, Mayu, Yamamoto, Harukaze, Shimizu, Chikako, Takahashi, Kazuhiro, Watanabe, Yasuyoshi, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado 2015